Literature DB >> 7581810

7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant.

S P Gieseg1, G Reibnegger, H Wachter, H Esterbauer.   

Abstract

Neopterin and its reduced form, 7,8 dihydroneopterin are pteridines released from macrophages and monocytes when stimulated with interferon gamma in vivo. The function of this response is unknown though there is an enormous amount of information available on the use of these compounds as clinical markers of monocyte/macrophage activation. We have found that in vitro 7,8-dihydroneopterin dramatically increases, in a dose dependent manner, the lag time of low density lipoprotein oxidation mediated by Cu++ ions or the peroxyl radical generator 2,2'-azobis (2-amidino propane) dihydrochloride (AAPH). 7,8-Dihydroneopterin also inhibits AAPH mediated oxidation of linoleate. The kinetic of the inhibition suggests that 7,8-dihydroneopterin is a potent chain breaking antioxidant which functions by scavenging lipid peroxyl radicals. No anti-oxidant activity was observed in any of the oxidation systems studied with the related compounds neopterin and pterin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581810     DOI: 10.3109/10715769509064027

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  5 in total

1.  Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.

Authors:  Angus Lindsay; Alexandra Schmiechen; Christopher M Chamberlain; James M Ervasti; Dawn A Lowe
Journal:  Exp Physiol       Date:  2018-07       Impact factor: 2.969

2.  7-ketocholesterol is not cytotoxic to U937 cells when incorporated into acetylated low density lipoprotein.

Authors:  Lucy D Rutherford; Steven P Gieseg
Journal:  Lipids       Date:  2011-11-29       Impact factor: 1.880

3.  Influence of neopterin and 7,8-dihydroneopterin on the replication of Coxsackie type B5 and influenza A viruses.

Authors:  Olga Bratslavska; Diana Platace; Edvīns Miklasevics; Dietmar Fuchs; Agris Martinsons
Journal:  Med Microbiol Immunol       Date:  2006-07-26       Impact factor: 3.402

Review 4.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

Review 5.  Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?

Authors:  Steven P Gieseg; Gregory Baxter-Parker; Angus Lindsay
Journal:  Antioxidants (Basel)       Date:  2018-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.